Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?

被引：0
|
作者：
Mieke Carlier
Sofie Carrette
Jason A Roberts
Veronique Stove
Alain Verstraete
Eric Hoste
Pieter Depuydt
Johan Decruyenaere
Jeffrey Lipman
Steven C Wallis
Jan J De Waele
机构：
[1] Microbiology and Immunology &Ghent University,Department of Clinical Chemistry,Department of Critical Care Medicine
[2] Ghent University,Department of Critical Care Medicine
[3] The University of Queensland,Burns Trauma and Critical Care Research Centre
[4] Ghent University Hospital,Department of Laboratory Medicine
[5] Royal Brisbane and Women’s Hospital,undefined
来源：
Critical Care | / 17卷
关键词：
β-lactam antibiotics; hyperfiltration; kidney function; pharmacokinetics; pharmacodynamics; therapeutic drug monitoring;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 13 条
  • [1] Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
    Carlier, Mieke
    Carrette, Sofie
    Roberts, Jason A.
    Stove, Veronique
    Verstraete, Alain
    Hoste, Eric
    Depuydt, Pieter
    Decruyenaere, Johan
    Lipman, Jeffrey
    Wallis, Steven C.
    De Waele, Jan J.
    CRITICAL CARE, 2013, 17 (03):
  • [2] A pilot study on pharmacokinetic/pharmacodynamic target attainment in critically ill patients receiving piperacillin/tazobactam
    Martinkova, Jirina
    Malbrain, Manu L. N. G.
    Havel, Eduard
    Safranek, Petr
    Bezouska, Jan
    Kaska, Milan
    ANAESTHESIOLOGY INTENSIVE THERAPY, 2016, 48 (01) : 23 - 28
  • [3] Pharmacodynamic Target Attainment for Cefepime, Meropenem, and Piperacillin-Tazobactam Using a Pharmacokinetic/Pharmacodynamic-Based Dosing Calculator in Critically Ill Patients
    Heil, Emily L.
    Nicolau, David P.
    Farkas, Andras
    Roberts, Jason A.
    Thom, Kerri A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (09)
  • [4] Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: A prospective observational study
    Dhaese, Sofie A. M.
    Thooft, Alexander D. J.
    Farkas, Andras
    Lipman, Jeffrey
    Verstraete, Alain G.
    Stove, Veronique
    Roberts, Jason A.
    De Waele, Jan J.
    JOURNAL OF CRITICAL CARE, 2019, 52 : 75 - 79
  • [5] Modified Augmented Renal Clearance score predicts rapid piperacillin and tazobactam clearance in critically ill surgery and trauma patients
    Akers, Kevin S.
    Niece, Krista L.
    Chung, Kevin K.
    Cannon, Jeremy W.
    Cota, Jason M.
    Murray, Clinton K.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2014, 77 : S163 - S170
  • [6] Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent infusion or continuous infusion
    Tournayre, Sarah
    Mathieu, Olivier
    Villiet, Maxime
    Besnard, Noemie
    Brunot, Vincent
    Daubin, Delphine
    Platon, Laura
    Corne, Philippe
    Klouche, Kada
    Larcher, Romaric
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 62 (02)
  • [7] Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis
    Asin-Prieto, Eduardo
    Rodriguez-Gascon, Alicia
    Troconiz, Inaki F.
    Soraluce, Amaia
    Maynar, Javier
    Angel Sanchez-Izquierdo, Jose
    Isla, Arantxazu
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (01) : 180 - 189
  • [8] A descriptive pharmacokinetic/pharmacodynamic analysis of ceftazidime-avibactam in a case series of critically ill patients with augmented renal clearance
    Xu, Ying
    Tang, Jian
    Yuan, Binbin
    Luo, Xuemei
    Liang, Pei
    Liu, Ning
    Dong, Danjiang
    Jin, Lu
    Ge, Weihong
    Gu, Qin
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2024, 12 (01):
  • [9] Early Target Attainment With Continuous Infusion Meropenem and Piperacillin/Tazobactam and Utilization of Therapeutic Drug Monitoring in Critically Ill Patients: A Retrospective Cohort Study From 2017 to 2020
    Drager, Sarah
    von Rotz, Matthias
    Labhardt, Niklaus D.
    Siegemund, Martin
    Rentsch, Katharina M.
    Osthoff, Michael
    Franzeck, Fabian C.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (04):
  • [10] Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort
    Abdul-Aziz, Mohd H.
    Lipman, Jeffrey
    Akova, Murat
    Bassetti, Matteo
    De Waele, Jan J.
    Dimopoulos, George
    Dulhunty, Joel
    Kaukonen, Kirsi-Maija
    Koulenti, Despoina
    Martin, Claude
    Montravers, Philippe
    Rello, Jordi
    Rhodes, Andrew
    Starr, Therese
    Wallis, Steven C.
    Roberts, Jason A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (01) : 196 - 207
12